Oxeia Biopharma named Most Innovative mTBI Biopharma Company 2025 by Global Health & Pharma

Written By Holly Plante

Read more about what’s behind Global Health & Pharma’s selection of Oxeia BioPharma as the Most Innovative mTBI Biopharma Company 2025

Read More

Holly Plante
Previous

Podcaster Mandi Dickey and Oxeia CEO Michael Wyand talk everything concussion.

Next

Neurotrauma Reports: Injection of Ghrelin (OXE-103) Improves Subacute Concussion Symptom Burden and Quality of Life